专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011025957A2 TG-APROTININ FUSION PROTEINS AND MATRICES THEREOF 审中-公开
标题翻译： TG-APROTININ融合蛋白及其基质
公开(公告)号：WO2011025957A2
公开(公告)日：2011-03-03
申请号：PCT/US2010/046991
申请日：2010-08-27
申请人： ECOLE POLYTECHNIQUE FEDERAL DE LAUSANNE , HUBBELL, Jeffrey, A. , FREY, Peter , LORENTZ, Kristen
发明人： HUBBELL, Jeffrey, A. , FREY, Peter , LORENTZ, Kristen
IPC分类号： A61L24/10
CPC分类号： A61L24/106 , A61L24/108 , A61L31/046 , A61L31/047
摘要： Fusion proteins containing a first domain and a second domain, where the first domain contains a crosslinkable substrate domain and the second domain contains a fibrinolysis inhibitor, are provided. In a preferred embodiment, the fibrinolysis inhibitor is a protease inhibitor, preferably, aprotinin. The fusion protein optionally contains a degradable site between the fist domain and the second domain. In a preferred embodiment, the crosslinkable substrate domain is a transglutaminase substrate domain, more preferably a Factor XIIIa substrate domain. Also provided is a method for decreasing the degradation of a fibrin matrix, and supplemented fibrin matrices with reduced degradation rates. The method includes covalently crossHnking a fusion protein containing a fibrinolysis inhibitor to the matrix. The supplemented fibrin matrices contain lower concentrations of a fibrinolysis inhibitor covalently bound to the matrix, compared to the concentration of unbound fibrinolysis inhibitor required to achieve the same reduction in degradation of the fibrin matrix.
摘要翻译：提供了含有第一结构域和第二结构域的融合蛋白，其中第一结构域含有可交联底物结构域并且第二结构域含有纤维蛋白溶解抑制剂。在一个优选的实施方案中，纤维蛋白溶解抑制剂是蛋白酶抑制剂，优选抑肽酶。融合蛋白任选地在第一结构域和第二结构域之间含有可降解位点。在优选的实施方案中，可交联底物结构域是转谷氨酰胺酶底物结构域，更优选是因子XIIIa底物结构域。还提供了一种降低纤维蛋白基质降解的方法，以及降低降解速率的补充纤维蛋白基质。该方法包括将含有纤维蛋白溶解抑制剂的融合蛋白共价交联到基质上。与实现纤维蛋白基质降解相同降低所需的未结合的纤维蛋白溶解抑制剂的浓度相比，补充的纤维蛋白基质含有较低浓度的与基质共价结合的纤维蛋白溶解抑制剂。

2. 发明申请

WO2007098254A2 NANOPARTICLES FOR IMMUNOTHERAPY 审中-公开
标题翻译：免疫治疗的纳米比亚
公开(公告)号：WO2007098254A2
公开(公告)日：2007-08-30
申请号：PCT/US2007/004671
申请日：2007-02-21
申请人： ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE , REDDY, Sai, T. , HUBBELL, Jeffrey, A. , SWARTZ, Melody, A. , VAN DER VLIES, Andre
发明人： REDDY, Sai, T. , HUBBELL, Jeffrey, A. , SWARTZ, Melody, A. , VAN DER VLIES, Andre
IPC分类号： A61K39/00
CPC分类号： A61K39/385 , A61K2039/55555 , A61K2039/6093
摘要： Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.
摘要翻译：描述了在不存在生物分子的情况下激活补体的纳米颗粒。显示出纳米颗粒特异性靶向抗原提呈细胞，特别是在淋巴结中，而不用生物分子进行靶向。这些颗粒是用于递送免疫治疗剂的有用载体。

3. 发明申请

WO2007008300A2 TRIBLOCK COPOLYMERS FOR CYTOPLASMIC DELIVERY OF GENE-BASED DRUGS 审中-公开
标题翻译：三嵌段共聚物用于基因组药物的细胞内输送
公开(公告)号：WO2007008300A2
公开(公告)日：2007-01-18
申请号：PCT/US2006/020760
申请日：2006-05-31
申请人： ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE , SEGURA, Tatiana , HUBBELL, Jeffrey, A.
发明人： SEGURA, Tatiana , HUBBELL, Jeffrey, A.
IPC分类号： C08G73/02
CPC分类号： C08F297/02 , A61L31/048 , C08L53/00 , C08L53/005
摘要： The invention features a triblock copolymer including a hydrophilic block; a hydrophobic block; and a positively charged block capable of reversibly complexing a negatively charged molecule, e.g., a nucleic acid, wherein the hydrophobic block is disposed between the hydrophilic block and the positively charged block. Desirably, the triblock copolymer is capable of self-assembling into a supramolecular structure, such as a micelle or vesicle. The invention further features methods of delivering negatively charged molecules and methods of treating a disease or condition using the polymers of the invention.
摘要翻译：本发明的特征在于包含亲水嵌段的三嵌段共聚物; 疏水性嵌段; 和能够可逆地络合带负电荷的分子（例如核酸）的带正电的嵌段，其中疏水嵌段位于亲水嵌段和带正电的嵌段之间。理想地，三嵌段共聚物能够自组装成超分子结构，例如胶束或囊泡。本发明进一步特征在于递送带负电的分子的方法和使用本发明的聚合物治疗疾病或病症的方法。

4. 发明申请

WO03024186A3 METHODS AND APPARATUS FOR PATTERNING A SURFACE 审中-公开
标题翻译：用于绘制表面的方法和装置
公开(公告)号：WO03024186A3
公开(公告)日：2003-05-22
申请号：PCT/US0229562
申请日：2002-09-18
申请人： EIDGENOESS TECH HOCHSCHULE , UNIV ZUERICH , HUBBELL JEFFREY A , BEARINGER JANE P , TEXTOR MARCUS
发明人： HUBBELL JEFFREY A , BEARINGER JANE P , TEXTOR MARCUS
IPC分类号： B41M3/00 , G03F7/00 , H01L21/302 , H01L21/461 , H01L51/00 , H01L51/40 , B44C1/22
CPC分类号： B29C43/003 , B29C2043/025 , B41M3/006 , C23F1/02 , G01Q80/00 , G03F7/0002 , H01L51/0015 , H01L51/0021
摘要： The present invention provides methods and apparatus for locally patterning surfaces. In one such method, an oxidizable thioether is adsorbed onto a conductive surface 10. The surface is then contacted with a fluid medium M. A conducting stamp 12 is then brought into contact with the fluid medium above the thioether-coated surface. Next, a potential V is applied between the stamp and the surface. It is expected that the charge will be transferred through the medium to the coated surface along a shortest distance path, thereby locally oxidizing the thioether and effectively creating a negative patterned image of the conducting stamp on the surface. Remaining adsorbed thioether may then be used as a mask for standard etching or material addition procedures.
摘要翻译：本发明提供了用于局部图案化表面的方法和装置。在一种这样的方法中，可氧化的硫醚被吸附到导电表面10上。然后使该表面与流体介质M接触。然后使导电印模12与硫醚涂覆表面上方的流体介质接触。接下来，在印模和表面之间施加电位V。预期电荷将沿着最短的距离路径通过介质转移到涂覆表面，从而局部氧化硫醚，并有效地在表面上产生导电印模的负图案图像。然后可以将剩余的吸附硫醚用作标准蚀刻或材料添加程序的掩模。

5. 发明申请

WO03024897A2 METHODS AND APPARATUS FOR COATING SURFACES TO REDUCE PROTEIN ADSORPTION AND CELL ADHESION AND PRESENT LIGANDS 审中-公开
标题翻译：用于涂覆表面以减少蛋白质吸附和细胞粘附和本发明配体的方法和装置
公开(公告)号：WO03024897A2
公开(公告)日：2003-03-27
申请号：PCT/US0229569
申请日：2002-09-18
申请人： EIDGENOESS TECH HOCHSCHULE , UNIV ZUERICH , HUBBELL JEFFREY A , BEARINGER JANE P , NAPOLI ALESSANDRO , TEXTOR MARCUS , TIRELLI NICOLA
发明人： HUBBELL JEFFREY A , BEARINGER JANE P , NAPOLI ALESSANDRO , TEXTOR MARCUS , TIRELLI NICOLA
IPC分类号： A61L27/34 , C07B
CPC分类号： A61L27/34 , C08L81/02
摘要： The present invention provides methods and apparatus for coating surfaces with specially designed thioethers and amphiphilic thioethers that reduce protein adsorption and/or cell adhesion. This reduction may be achieved, for example, by controlling the spacing or length of pendant chains or hydrophilic blocks in an amphiphilic thioether. Techniques for determining spacing include adsorbing the thioether from a solution or a colloidal suspension, or controlling the degree of polymerization of the thioether. Techniques for controlling the length of the pendant chains include controlling the degree of polymerization of the pendant chains. Multiblock copolymers of poly(propylene sulfide) and poly(ethylene glycol) ("PPS-PEG") represent an exemplary family of amphiphilic thioethers. Methods for coating surfaces with amphiphilic thioethers are also provided.
摘要翻译：本发明提供了用特别设计的硫醚和两亲硫醚涂覆表面的方法和装置，其减少蛋白质吸附和/或细胞粘附。该还原可以通过例如通过控制两亲性硫醚中的侧链或亲水嵌段的间隔或长度来实现。用于确定间隔的技术包括从溶液或胶体悬浮液中吸附硫醚，或控制硫醚的聚合度。用于控制侧链长度的技术包括控制侧链的聚合度。聚（丙烯硫醚）和聚（乙二醇）（“PPS-PEG”）的多嵌段共聚物代表两亲性硫醚的典型族。还提供了用两亲硫醚涂覆表面的方法。

6. 发明申请

WO2002074158A2 TWO-PHASE PROCESSING OF THERMOSENSITIVE POLYMERS FOR USE AS BIOMATERIALS 审中-公开
标题翻译：用作生物材料的热敏聚合物的两相加工
公开(公告)号：WO2002074158A2
公开(公告)日：2002-09-26
申请号：PCT/US2002/008537
申请日：2002-03-20
申请人： EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH , UNIVERSITAT ZURICH , CELLESI, Francesco , TIRELLI, Nicola , HUBBELL, Jeffrey, A.
发明人： CELLESI, Francesco , TIRELLI, Nicola , HUBBELL, Jeffrey, A.
IPC分类号： A61B
CPC分类号： C07K1/1077 , A61K9/1641 , A61K35/12 , A61L24/0015 , A61L24/0031 , A61L27/52 , A61L27/54 , A61L31/145 , A61L2300/232 , A61L2300/25 , A61L2300/252 , A61L2300/258 , A61L2300/45 , A61L2300/62
摘要： A two-step system for preparing biomaterials from polymeric precursors is disclosed. The method involves (a) shaping the polymeric precursors by inducing thermal gelation of an aqueous solution of the polymeric precursors and (b) curing the polymeric precursors by cross-linking reactive groups on the polymeric precursors to produce a cured material. The curing reaction involves either a Michael-type addition reaction or a free radical photopolymerization reaction in order to cross-link the polymeric materials. The biomaterials produced by this method have a variety of biomedical uses, including drug delivery, microencapsulation, and implantation.
摘要翻译：公开了一种用于从聚合物前体制备生物材料的两步系统。该方法包括（a）通过引发聚合物前体的水溶液的热凝胶形成聚合物前体，和（b）通过在聚合物前体上交联反应性基团固化聚合物前体以产生固化的材料。固化反应涉及迈克尔型加成反应或自由基光聚合反应以交联聚合材料。通过该方法生产的生物材料具有各种生物医学用途，包括药物递送，微囊化和植入。

7. 发明申请

WO0183522A2 GROWTH FACTOR MODIFIED PROTEIN MATRICES FOR TISSUE ENGINEERING 审中-公开
标题翻译：生长因子改良组织工程蛋白质矩阵
公开(公告)号：WO0183522A2
公开(公告)日：2001-11-08
申请号：PCT/US0011947
申请日：2000-05-01
申请人： ETH ZUERICH , HUBBELL JEFFREY A
发明人： HUBBELL JEFFREY A , SCHENSE JASON C , SAKIYAMA-ELBERT SHELLY E
IPC分类号： A61K31/727 , A61K31/737 , A61K38/17 , A61K47/48 , A61L27/00 , A61L27/20 , A61L27/22 , A61L27/54 , A61L33/00 , A61P41/00 , A61P43/00 , C07K1/04 , C07K14/495 , C07K14/52 , C07K14/745 , C07K19/00 , C07K14/00
CPC分类号： A61L27/20 , A61K47/61 , A61K47/62 , A61L27/227 , A61L27/54 , A61L2300/236 , A61L2300/252 , A61L2300/414 , A61L2300/604
摘要： Proteins are incorporated into protein or polysaccharide matrices for use in tissue repair, regeneration and/or remodeling and/or drug delivery. The proteins can be incorporated so that they are released by degradation of the matrix, by enzymatic action and/or diffusion. As demonstrated by the examples, one method is to bind heparin to the matrix by either covalent or non-covalent methods, to form a heparin-matrix. The heparin then non-covalently binds heparin-binding growth factors to the protein matrix. Alternatively, a fusion protein can be constructed which contains a crosslinking region such as a factor XIIIa substrate and the native protein sequence. Incorporation of degradable linkages between the matrix and the bioactive factors can be particularly useful when long-term drug delivery is desired, for example in the case of nerve regeneration, where it is desirable to vary the rate of drug release spatially as a function of regeneration, e.g. rapidly near the living tissue interface and more slowly farther into the injury zone. Additional benefits include the lower total drug dose within the delivery system, and spatial regulation of release which permits a greater percentage of the drug to be released at the time of greatest cellular activity.
摘要翻译：将蛋白质掺入用于组织修复，再生和/或重塑和/或药物递送的蛋白质或多糖基质中。可以掺入蛋白质，使其通过降解基质，通过酶作用和/或扩散来释放。如实施例所示，一种方法是通过共价或非共价方法将肝素与基质结合，形成肝素基质。然后肝素将肝素结合生长因子非共价结合到蛋白质基质上。或者，可以构建融合蛋白，其包含交联区域，例如因子XIIIa底物和天然蛋白质序列。当需要长期药物递送时，例如在神经再生的情况下，在基质和生物活性因子之间引入可降解的键可能是特别有用的，其中期望在空间上改变作为再生的功能的药物释放速率，例如快速靠近生物组织界面，并进一步向进入损伤区更慢。额外的益处包括递送系统内的总药物剂量越少，释放的空间调节，允许在最大的细胞活动时释放更多百分比的药物。

8. 发明申请

WO2011025957A3 TG-APROTININ FUSION PROTEINS AND MATRICES THEREOF 审中-公开
标题翻译： TG-APROTININ融合蛋白及其基因
公开(公告)号：WO2011025957A3
公开(公告)日：2011-07-07
申请号：PCT/US2010046991
申请日：2010-08-27
申请人： ECOLE POLYTECH , HUBBELL JEFFREY A , FREY PETER , LORENTZ KRISTEN
发明人： HUBBELL JEFFREY A , FREY PETER , LORENTZ KRISTEN
IPC分类号： A61L24/10
CPC分类号： A61L24/106 , A61L24/108 , A61L31/046 , A61L31/047
摘要： Fusion proteins containing a first domain and a second domain, where the first domain contains a crosslinkable substrate domain and the second domain contains a fibrinolysis inhibitor, are provided. In a preferred embodiment, the fibrinolysis inhibitor is a protease inhibitor, preferably, aprotinin. The fusion protein optionally contains a degradable site between the fist domain and the second domain. In a preferred embodiment, the crosslinkable substrate domain is a transglutaminase substrate domain, more preferably a Factor XIIIa substrate domain. Also provided is a method for decreasing the degradation of a fibrin matrix, and supplemented fibrin matrices with reduced degradation rates. The method includes covalently crossHnking a fusion protein containing a fibrinolysis inhibitor to the matrix. The supplemented fibrin matrices contain lower concentrations of a fibrinolysis inhibitor covalently bound to the matrix, compared to the concentration of unbound fibrinolysis inhibitor required to achieve the same reduction in degradation of the fibrin matrix.
摘要翻译：提供了含有第一结构域和第二结构域的融合蛋白，其中第一结构域含有可交联的底物结构域，第二结构域含有纤维蛋白溶解抑制剂。在优选的实施方案中，纤维蛋白溶解抑制剂是蛋白酶抑制剂，优选抑肽酶。融合蛋白任选地包含第一结构域和第二结构域之间的可降解位点。在优选的实施方案中，可交联底物结构域是转谷氨酰胺酶底物结构域，更优选因子XIIIa底物结构域。还提供了降低纤维蛋白基质降解的方法，以及降低降解速率的补充的纤维蛋白基质。该方法包括将含有纤维蛋白溶解抑制剂的融合蛋白共价交叉到基质上。与实现纤维蛋白基质降解相同的降低所需的未结合的纤维蛋白溶解抑制剂的浓度相比，补充的纤维蛋白基质含有较低浓度的与基质共价结合的纤维蛋白溶解抑制剂。

9. 发明申请

WO2010002450A2 MICELLES FOR DELIVERY OF NITRIC OXIDE 审中-公开
标题翻译：用于递送一氧化氮的胶束
公开(公告)号：WO2010002450A2
公开(公告)日：2010-01-07
申请号：PCT/US2009/003885
申请日：2009-06-30
申请人： ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE , HUBBELL, Jeffrey, A. , JO, Yun, Suk , VAN DER VLIES, Andre
发明人： HUBBELL, Jeffrey, A. , JO, Yun, Suk , VAN DER VLIES, Andre
IPC分类号： A61K9/127 , A61K33/00 , A61K47/34 , A61P9/10
CPC分类号： A61K31/77 , A61K9/1075 , A61K9/1273 , A61K31/787 , A61K31/80 , A61K47/48176 , A61K47/488 , A61K47/58 , A61K47/6907 , Y10S977/906
摘要： Embodiments include a vehicle for delivery of nitric oxide comprising: a collection of micelles having an internal micelle core that comprises a polymer with N-diazeniumdiolate comprising NO complexed with secondary amines of the polymer. Embodiments include a method of making a nitric oxide vehicle comprising dissolving a polymer that comprises secondary amines in an aqueous solution and combining the polymer with nitric oxide in the solution to form a N-diazeniumdiolate comprising the nitric oxide complexed with the secondary amines, with the formation of the N-diazeniumdiolate causing the polymer to be at least partially insoluble in the solution and to form a collection of micelles that have an internal core that comprises N-diazeniumdiolate.
摘要翻译：实施方案包括用于递送一氧化氮的媒介物，其包含：具有内部胶束核心的胶束集合体，所述内部胶束核心包含具有包含与聚合物的仲胺络合的NO的N-二醇二氮烯鎓的聚合物。实施方案包括制备一氧化氮载体的方法，所述方法包括将包含仲胺的聚合物溶解在水溶液中并且将聚合物与一氧化氮在溶液中结合以形成包含与仲胺络合的一氧化氮的N-二醇二氮烯鎓， N-二醇二氮烯鎓的形成导致聚合物至少部分不溶于溶液中并形成具有包含N-二氮烯鎓二醇化物的内核的胶束集合。

10. 发明申请

WO2008063291A3 POLYPEPTIDE LIGANDS FOR TARGETING CARTILAGE AND METHODS OF USE THEREOF 审中-公开
标题翻译：用于靶向治疗的多肽配体及其使用方法
公开(公告)号：WO2008063291A3
公开(公告)日：2008-10-02
申请号：PCT/US2007021529
申请日：2007-10-09
申请人： ECOLE POLYTECH , HUBBELL JEFFREY A , ROTHENFLUH DOMINIQUE A
发明人： HUBBELL JEFFREY A , ROTHENFLUH DOMINIQUE A
IPC分类号： C12N15/00 , A61K38/04 , A61K39/00 , C07H21/04
CPC分类号： C07K7/06
摘要： Ligands that specifically bind to articular cartilage tissues are disclosed, including uses for targeting therapeutics towards articular cartilage tissue and new materials for articular cartilage. The ligands are effective in vivo to target therapeutic materials to articular cartilage.
摘要翻译：公开了特异性结合关节软骨组织的配体，包括用于将治疗剂靶向关节软骨组织的用途和用于关节软骨的新材料。配体在体内是有效的，以将治疗材料靶向关节软骨。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式